DOCSLIB.ORG

Connecting and Collaborating

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Connecting and Collaborating CONNECTING AND COLLABORATING Five years of growing life sciences within London and the greater south east of England 2 CONNECTING AND COLLABORATING Introduction In 2014 the Mayor of London and south east and the UK digital health Alan Turing Institute for data the London Academic Health Science segment employs 11,000 people with science and AI. Last but not least, Centres launched MedCity with a a turnover of £1.4 billion1. Nearly we have had two Life Sciences Sector clear purpose. MedCity was to unite a quarter of Europe’s advanced Deals which are fully aligned with the elements of our life sciences sector therapy medicinal product (ATMP) the sector’s interests. to allow it to reach its full economic developers are headquartered in the potential on a world stage. UK2, and we are using licensed cell Five years on from its launch, Eliot Forster, and gene therapies to treat 100s of MedCity’s fundamental purpose to Chair MedCity At the time we knew we were at the patients in UK hospitals3. Last year enable the life sciences sector to beginning of an era of new healthcare we completed the 100,000 genomes deliver economic growth remains innovations in terms of digital health project and, in the next five years, intact. Despite political upheavals, technologies, advanced therapeutics, the government will expand it to see the sector continues to deliver and, genomics and big data. As a city, a 1 million whole genomes sequenced. through wider collaboration across region and a country, we had a world- This makes London the only city in the geographical boundaries, we can leading advantage in these fields, but world fully ready to take on the next ensure the UK life sciences sector has we had to be committed and cohesive life sciences challenges where data the leading position it deserves on a to ensure we could convert this into meets biology meets AI. global stage. a life sciences sector that would be internationally competitive and We have seen the development Together with its partners, MedCity contribute to the nation’s health. of world-leading institutes, such will continue to work to achieve as the Francis Crick Institute, the its objectives and, like the sector it Over the five years since our UK Dementia Research Institute represents, it will do so passionately, launch, MedCity has listened to the headquartered at UCL and the innovatively and effectively. sector and put in a place a wealth of impactful initiatives. Thanks to the enduring support of the London 1 BioScience and Health Funded by Technology Sector AHSCs, we have seen collaboration Statistics, Office for Life becoming more widespread and more Sciences, 2018 intuitive, and the effects of this are 2 The UK’s ATMP Landscape, BIA and visible in our region and more widely Alliance for Regenerative across the UK landscape. Medicine, 2019 In Collaboration with 3 Cell & Gene Therapy Catapult Annual Review, We have a thriving digital health 2019 community in London and the greater 3 MedCity DigitalHealth. Launch of our London is FEB FEB ‘Collaborate launched with to Innovate’ MedCity as one programme to fund MedCity is a not-for-profit organisation that of the founding life sciences SMEs delivery partners works across London and the greater south east to collaborate 2016 alongside the of England to connect the life sciences excellence with academics on London AHSNs of our academic institutes, our companies and our research healthcare system. Launched in 2014, our aim is to promote and grow life sciences investment, entrepreneurship and industry. Our report ‘Demand for APR healthcare R&D space in London’ is published By drawing on the expertise of our founders and by listening We take our first which helps form to the different voices within our ecosystem, we establish OCT delegation to the vision for several BioJapan and launch innovative developments activities and initiatives to provide deeper, more effective our report on ‘Cell across London collaboration and to raise awareness globally of the region’s and gene therapy in rich life sciences cluster. London, Oxford and Cambridge’ 2017 We are extremely grateful to our funders and supporters for the foresight and long-term commitment to this project, Our ‘London Life JUL Sciences in focus’ which has allowed MedCity to add value to the life sciences report is published We organise the ecosystem over the last five years. FEB first showcase event for NIHR Biomedical Research Centres in the region We co-host JAN the first Future of Healthcare Our ‘Neuroscience Investor Forum APR Network’ report is with the London published on research 2015 Stock Exchange on neurodegenerative disease in the region 2014 APR JUN OCT Launch of We take our first Launch of Angels MedCity delegation to in MedCity Bio International programme Convention in the US 4 CONNECTING AND COLLABORATING 2019 FEB FEB MAR APR NICE publishes Our CEO gives The British Library MedCity Our front door DEC evidence standards evidence to signs an agreement becomes an serves our 1000th framework for the House of for the creation endorsing body new client since digital healthcare Commons Science of a new R&D for life sciences our launch in 2014 technologies. and Technology hub in London’s innovator and We are on the Select Committee Knowledge Quarter start-up visas working group on balance of R&D – MedCity worked spending with partners to evolve the vision Together with NOV London Advanced Therapies we launch the Advanced Our Therapies Network (ATN) for academics, highlights 1000 £5.6M companies and clients raised investors We become 1000 new clients Three rounds of 77 companies on Angels JAN a supporter from across academia, Collaborate to Innovate in MedCity raising over of the NHS industry and the NHS - bringing together SMEs £5.6 million through the England Clinical over a third from and academics on programme1 Entrepreneur outside the UK research projects 2018 Training See page 20 Programme See page 14 See page 18 Business Minister, OCT Lord Prior, joins MedCity delegation to BioJapan Over 480 members2 in Eleven MedCity Five Future of 10,000 views3 of the Advanced Therapies delegations to Healthcare Investor the NICE evidence Network (ATN) leading international Forums co-hosted standards framework See page 19 conventions with the London Stock for digital healthcare See page 14 Exchange technologies – MedCity See page 20 leads on industry 1 As of 04/2019 engagement 2 As of 09/2019 See page 24 3 As of 09/2019 5 Our partners MedCity works in partnership with a range of Standards and Guidance organisations. We owe the success of our initiatives to 37 British Standards Institute their shared ambition and motivation in realising our goal 38 National Institute for Health and of a more connected, productive life sciences sector for Care Excellence the region and the UK. Trade bodies and Associations 39 Association of British HealthTech Industries (ABHI) 40 National Research and Innovation NHS Research and Innovation UK BioIndustry Association (BIA) 41 The Institution of Engineering and 1 National Phenome Centre 21 NHS Health Research Authority Technology 2 The Institute of Cancer Research 22 NIHR Cardiovascular MedTech 42 Association of British 3 Cell and Gene Therapy Catapult Co-operative Pharmaceutical Industry (ABPI) 23 4 Genomics England NIHR Applied Research Japan Collaboration Northwest London 5 Medicines Discovery Catapult Link-J 24 NIHR Brain Injury MedTech 6 Cardiovascular Device Hub Japanese BioIndustry Association Co-operative 7 The Francis Crick Institute 25 UCL Partners Accelerators, Incubators 8 Innovate UK 26 Imperial College Academic Health and Science Parks 9 NIHR Invention for Innovation Science Centre 43 Co-Innovate (i4i) Programme 27 King’s Health Partners 44 DigitalHealth.London Accelerator 28 NIHR Biomedical Research Centres Eastern Academic Health Science 45 MedTech SuperConnector Network (EAHSN) 10 Oxford BRC 46 NHS Innovation Accelerator 29 Imperial College Health Partners 11 Cambridge BRC 47 Oxford BioEscalator 30 Health Innovation Network 12 GOSH BRC 48 Simulation for Digital Health 31 Northern Alliance ATTC (SimDH) 13 Royal Marsden BRC 32 iMATCH ATTC 49 NHS England Clinical Entrepreneur 14 Imperial BRC 33 Midland Wales ATTC Training Programme 15 Guy’s and St Thomas’ BRC 34 NIHR London IVD Co-operative 50 Immerse UK 16 Moorfields BRC 35 NIHR Community Healthcare 51 Health Foundry 17 University College London MedTech and In Vitro Diagnostics 52 Milton Park Hospitals BRC Co-operative 53 Discovery Park Kent 18 Oxford Health BRC 36 Wessex AHSN 54 Stevenage Bioscience Catalyst 19 Maudsley BRC 20 Barts BRC 6 CONNECTING AND COLLABORATING Regional organisation 55 DigitalHealth.London 56 London & Partners 57 EDINBURGH Northern Health Science Alliance 31 (NHSA) 58 Invest Essex 59 South East Health Technologies CAMBRIDGE Alliance (SEHTA) 60 Health Innovation Research Alliance 31 Northern Ireland (HIRANI) Ipswich NEWCASTLE 61 Life Sciences Hub Wales 62 London Advanced Therapies BELFAST Milton Keynes 32 63 One Nucleus 60 49 M1 M11 Colchester LEEDS New York 57 26 New York City Economic Development Corporation MANCHESTER 5 OXFORD 32 LIVERPOOL LONDON 33 M25 M40 CAMBRIDGE 11 24 56 44 7 33 63 20 41 28 17 36 6 47 54 12 50 16 10 Reading 42 29 4 62 M4 26 OXFORD 14 46 25 39 35 18 9 52 LONDON 19 30 55 56 43 CARDIFF (see inset) 57 33 61 8 45 21 48 33 34 53 1 3 15 22 23 40 2 51 27 Canterbury 13 38 36 37 M25 M20 M3 Dover 7 Hastings Brighton Portsmouth Impact in numbers MedCity front door service Angels in MedCity (Oct 2014 to April 2019) Cumulative number 994 of new clients
Load more

Recommended publications
  • London: an Innovation Hub for Health & Life Sciences Through
    LONDON: AN INNOVATION HUB FOR HEALTH & LIFE SCIENCES THROUGH THE APPLICATION OF DATA AND AI SUPPORTED BY Next page Access the market: 19 from NHS to Biopharma CONTENTS Foreword 3 The NHS adoption of AI technologies 20 This is an interactive guide, London’s key strengths 4 l Spotlight on UCLPartners 21 so click on the title to jump to any section. An Innovative Biopharma Cluster 22 An ecosystem built for growth 5 l Case study - MultiplAI 23 Access to funding 6 Government support 7 An accessible, diverse 24 l Case study - Kheiron Medical 9 and data-rich environment Diverse population and data 24 London’s life sciences clusters 10 Partner with the Health Data 25 The Knowledge Quarter 11 Research Hubs Whitechapel: Barts Life Sciences Hub 12 l Spotlight on DATA-CAN HDR 26 White City Innovation District 13 Southbank to Sutton 14 London’s resilient COVID-19 response 27 l Case study - InstaDeep 28 Talent and educational excellence 15 Existing talent 16 How can we help 29 The next generation 17 How London & Partners can support 29 l Case study - PEP Health 18 How MedCity can support 29 2 Contents page FOREWORD COVID-19 has accelerated data-driven innovation across often siloed organisations. Similarly, policy is being the globe, with artificial intelligence and data science at developed to overcome legacy systems and regulations, the forefront of addressing human disease and health. which will underpin and speed up innovations. The coronavirus pandemic has led to increased acceptance of new technologies with strong buy-in from all corners Not only can bioinformatics and use of healthcare Allen Simpson Neelam Patel data lead to better health systems and outcomes, this of the life sciences and healthcare sector determined to CEO also has the potential to create many new jobs Acting CEO keep this momentum going.
    [Show full text]
  • Life Sciences Sector Deal 2 Industrial Strategy Life Sciences Sector Deal 2 Foreword
    Industrial Strategy Life Sciences Sector Deal 2 Industrial Strategy Life Sciences Sector Deal 2 Foreword Last year the Life Sciences develops to encourage and spread Sector Deal set out the first these new technologies. Advanced phase of implementing the Life therapies are making precision Sciences Industrial Strategy medicines, targeted to the individual patient, a reality here in the UK. through joint commitments between the government This second Life Sciences Sector Rt Hon Greg Clark MP and the sector to invest in the Deal deepens our partnership with industry, universities and charities and United Kingdom’s life sciences Secretary of State for Business, demonstrates how the NHS is pivotal as Energy and Industrial Strategy landscape. a delivery partner. It contains significant The agreements made in the first action to address the Industrial Strategy deal capitalised on the enormous Grand Challenges and our mission to opportunities for growth that the life transform the prevention, diagnosis sciences sector presents for the UK. and treatment of chronic diseases by We are seeing a continual flow of new 2030: it will support the creation of a investments across the health tech cohort of healthy participants that will and pharmaceutical sectors since the enable research into the hidden signs deal was published, with this year’s of disease and ways of diagnosing Rt Hon Matt Hancock MP second deal seeing more life sciences diseases early when interventions Secretary of State for companies investing in the UK and and treatments can be the most Health and Social Care creating high-quality, well-paid jobs. effective. The cohort will involve the public, the research community and Life sciences is a sector that operates industry with the results benefiting at the cutting-edge of technological the whole health service – an example developments.
    [Show full text]
  • Helen Lawton Smith & Sharmistha Bagchi-Sen
    The London-Oxford-Cambridge (Southeast) Golden Research Triangle: hype or reality? -- A bio-innovation complex to overtake US Helen Lawton Smith & Sharmistha Bagchi-Sen Presentation at CIMR workshop, June 29 2016 Focus of the presentation (i) the incentives for leading UK entrepreneurial universities to work together in this project and the inherent facilitators and inhibitors, – organizational factors facilitating or hindering endeavours where inter-organisational collaboration is required (ii) the value-added from being where they are and the extent of accrued local cluster assets that they bring to the venture – the existing landscape of translational research and the extent to which local factors facilitate the process (iii) how the hierarchies of policies (local, national) shape the environment for collective action, – how can such actions be evaluated? The talk structure 1. UK context 2. Barriers and potential of "golden triangle” 3. MedCity in theory and practice 4. Reflections on prospects Research questions • What are the factors which will influence whether or not the MedCity initiative will be sustainable? • What is different now compared to earlier efforts to build a biomedical science cluster in London? – E.g. 2006 – plan for Global Medical Excellence Cluster Context • UK Industrial Strategy for Life Science (2011) proposes that the UK is made into “a world-leading place for life sciences investment and a global hub for life sciences” (page 4). UK Context • Pharmaceuticals, medical biotechnology and medical technology sectors together comprise around 4,500 firms, employing 165,000 staff, with an R&D spend of nearly £5billion and an annual turnover of over £50 billion. • Of the top 50 global pharmaceutical companies, 37 have sites in the UK • Largest biopharmaceutical pipeline in the EU – 20% • Life sciences map of companies – 3 largest centres are in Golden triangle Important initiatives in life sciences research and translation • Francis Crick Institute (opening 2016) – The Crick aspires to be one of the world's leading medical research institutes.
    [Show full text]
  • Life Sciences in London and the South East 02–03 Medcity at a Glance: Life Sciences in London and the South East Welcome
    At a glance Life sciences in London and the south east 02–03 MedCity At a glance: Life sciences in London and the south east Welcome The ‘golden triangle’ is the The golden triangle is being boosted world-leading life sciences cluster further by a wave of significant new of London, Oxford, Cambridge and investment, including: England’s greater south east. The Francis Crick Institute – At a glance: Life sciences in London bringing together 1,500 scientists and the south east has been created under one roof to help you navigate this exciting Imperial West – co-locating ecosystem. It provides a snapshot of researchers and businesses this evolving community, its current on 25 acres strengths and the plans for future UCL East – a cross-discipline investment and growth. enterprise and innovation centre focused on health and biological This cluster is a rich network of technologies on the site of renowned research centres, healthcare Queen Elizabeth Olympic Park providers and medical charities, The Institute of Cancer Research innovative SMEs and large industry – creating the world’s second largest players, all based within a compact and cancer research campus in south London well-connected geographical region. AstraZeneca’s Global R&D Centre – bringing together 2,000 employees in Cambridge This region is a hotbed of innovation, home to: To maximise this wave of new investment four of the world’s top MedCity was launched in April 2014. 10 universities This unique enterprise is your portal to five out of seven of the UK’s the diverse expertise, innovation and academic health science centres infrastructure of the region.
    [Show full text]
  • Employment Land Needs Assessment
    Employment Land Needs Assessment Oxford City Council Final Report October 2018 Prepared by GL Hearn 280 High Holborn London WC1V 7EE T +44 (0)20 7851 4900 glhearn.com Employment Land Needs Assessment October 2018 Oxford City Council, Final Report Contents Section Page 1 EXECUTIVE SUMMARY 4 2 INTRODUCTION 7 3 REVIEW OF RECENT EVIDENCE 8 4 PROPERTY DYNAMICS 13 5 EMPLOYMENT FORECASTING 22 6 EMPLOYMENT LAND NEEDS 31 GL Hearn Page 2 of 38 Employment Land Needs Assessment October 2018 Oxford City Council, Final Report Quality Standards Control The signatories below verify that this document has been prepared in accordance with our quality control requirements. These procedures do not affect the content and views expressed by the originator. This document must only be treated as a draft unless it is has been signed by the Originators and approved by a Business or Associate Director. DATE ORIGINATORS APPROVED October 2018 Nena Pavlidou Paul McColgan Senior Planner Associate Director Limitations This document has been prepared for the stated objective and should not be used for any other purpose without the prior written authority of GL Hearn; we accept no responsibility or liability for the consequences of this document being used for a purpose other than for which it was commissioned. GL Hearn Page 3 of 38 Employment Land Needs Assessment October 2018 Oxford City Council, Final Report 1 EXECUTIVE SUMMARY i. There are an estimated 135,400 jobs in Oxford in 2016. Oxfordshire is home to some of the UK’s principal locations for high quality knowledge-based economic growth. Firstly, the University of Oxford has the country’s largest volume of world-leading research companies.
    [Show full text]
  • London's Innovation Districts
    SPACES TO THINK: INNOVATION DISTRICTS AND THE CHANGING GEOGRAPHY OF LONDON’SKat Hanna KNOWLEDGE ECONOMY SPACES TO THINK: INNOVATION DISTRICTS AND THE CHANGING GEOGRAPHY OF LONDON’S KNOWLEDGE ECONOMY Kat Hanna Published by Centre for London, April 2016 Open Access. Some rights reserved. As the publisher of this work, Centre for London wants to encourage the circulation of our work as widely as possible while retaining the copyright. We therefore have an open access policy which enables anyone to access our content online without charge. Anyone can download, save, perform or distribute this work in any format, including translation, without written permission. This is subject to the terms of the Centre for London licence. Its main conditions are: · Centre for London and the author(s) are credited · This summary and the address www.centreforlondon.org are displayed · The text is not altered and is used in full · The work is not resold · A copy of the work or link to its use online is sent to Centre for London. You are welcome to ask for permission to use this work for purposes other than those covered by the licence. Centre for London gratefully acknowledges the work of Creative Commons in inspiring our approach to copyright. To find out more go to www.creativecommons.org Published by: Centre for London 2016 © Centre for London. Some rights reserved. 1 Plough Place London EC4A 1DE T: 020 3757 5555 [email protected] www.centreforlondon.org Company Number: 8414909 Charity Number: 1151435 Typeset by Soapbox, www.soapbox.co.uk Centre for London is a politically independent, not‑for‑profit think tank focused on the big challenges facing London.
    [Show full text]
  • 2018 Programme
    Shifting perceptions? The challenges and opportunities of the Fourth Industrial Revolution 28 November 2018 2 3 Contents Agenda 11.00 Registration and networking Today, the Huxley Summit will bring together leaders from 12.00 Chapter 1: The changing tide of public perception Since the 1950s, plastic has been seen as a problem-solving wonder. However, business, policy-making and science to discuss how we can the recent public and media reaction to single-use plastics following Blue ensure products of innovation are fit for purpose as societal, Planet II has raised many questions for businesses, policy-makers and scientists. How do businesses create confidence and trust from consumers in environmental and cultural expectations change and shift. How products that could impact society and the environment? How do institutions does society overcome the challenges of the ‘Fourth Industrial manage this risk and learn from past decisions? Revolution’ and a potential breakdown of trust in technology Speakers include: Liz Bonnin, Zoe Laughlin, Emma Howard Boyd, Rory Sutherland, Baroness Lucy Neville-Rolfe from the public? There will be provocations and debates, plus time for networking and focussed discussions about how we 13.20 Roundtable discussions and lunch navigate the future. 14.50 Chapter 2: Preparing for the future Part A: Short-term challenges vs. long-term risks How can leaders in boardrooms and government consider changing perceptions in different technical and cultural spheres to create responsible innovations? This panel will discuss how boards can balance long-term risks Page 3 Agenda and impacts with short-term challenges. Page 4 Welcome Speakers include: Linda Yueh, Marisa Drew, David Bucknall Part B: Artificial perceptions of AI? Page 6 Public opinion is Artificial intelligence is heralded by technologists, business leaders, and policy- powerful and makers as a wonder technology with the potential to solve global problems unpredictable such as health, climate change, and inequality.
    [Show full text]
  • Mapping the Landscape of UK Health Data Research & Innovation
    Mapping the Landscape of UK Health Data Research & Innovation A snapshot of activity in 2017 Dr Ekaterini Blaveri October 2017 CONTENTS Foreword 5 1. Background to this review 7 1.1. Aims 8 1.2. Scope and sections 8 1.3. Approach 9 1.4. Challenges 10 1.5. Acknowledgements 10 2. Overview of major informatics investments by Funder 11 2.1. MRC 12 2.1.1. The Farr Institute of Health Informatics Research 12 2.1.2. MRC Medical Bioinformatics initiative 16 2.1.3. MRC Capital Investment in Genomics England Data Infrastructure 19 2.2.1. The NIHR Biomedical Research Centres 21 2.2.2. The NIHR Health Informatics Collaborative programme 22 2.2.3. The NIHR Collaboration for Leadership in Applied Health Research and Care 25 2.3. Department of Health and Social Care 26 2.3.1. Academic Health Science Centres 26 2.3.2. Genomics England | 100,000 Genomes Project 27 2.4. NHS 28 2.4.1. Academic Health Science Networks 28 2.4.2. NHS Genomic Medicine Centres 30 2.4.3. NHS Global Digital Exemplars 31 2.5. ESRC’s investments in Big Data 32 2.5.1. Administrative Data Research Network 32 2.6. EPSRC’s health data research investments 33 3. Key informatics investments by Research Organisation 35 England – East Anglia and Midlands 38 University of Cambridge 41 EMBL-European Bioinformatics Institute 48 Wellcome Sanger Institute 52 University of Birmingham 56 University of Leicester 62 University of Warwick 68 England – London 74 Imperial College London 76 King’s College London 85 London School of Hygiene and Tropical Medicine 94 Queen Mary University of London 98 University
    [Show full text]
  • Accessing Research and Clinical Expertise Accessing Research And
    Accessing researchResearch and Clinical Expertise in LondonCambridge, and London,the South Oxford East and the Greater South East 1 About the NIHR The National Institute for Health Research (NIHR) is funded by the Department of Health to improve the health and wealth of the nation through research. Since its establishment in April 2006, the NIHR has transformed research in the NHS. It has increased the volume of applied health research for the benefit of patients and the public, driven faster translation of basic science discoveries into tangible nihr.ac.uk benefits for patients and the economy, and developed and supported the people @officialNIHR who conduct and contribute to applied health research. The NIHR plays a key role in the Government’s strategy for economic growth, attracting investment by the life-sciences industries through its world-class infrastructure for health research. Together, the NIHR people, programmes, centres of excellence and systems represent the most integrated health research system in the world. About NOCRI The NIHR Office for Clinical Research Infrastructure (NOCRI) helps public, charity and industry research funders work in partnership with NIHR infrastructure and to maximise the impact of the Department of Health’s £0.5b/year investment in clinical research infrastructure. Equally, it ensures that NIHR-supported centres, units, facilities and networks can work together to help drive the flow of innovative research for patient benefit. nihr.ac.uk/nocri NOCRI supports research partners by: @NIHR_NOCRI • Research signposting - help with navigating the clinical research environment and finding expert researchers and world class facilities and technologies • Research collaboration management - support for the development of collaborative research partnerships About MedCity MedCity exists to promote and grow life sciences investment, entrepreneurship, collaboration and industry in Cambridge, London, Oxford and the greater south east.
    [Show full text]
  • Downloads/Collabor.Pdf
    Geographical clusters (March 2015) Summary of a FORUM workshop held on 3 March 2015 hosted jointly by the Academy of Medical Sciences and the Wellcome Trust. The Academy of Medical Sciences The Academy of Medical Sciences is the independent body in the UK representing the diversity of medical science. Our mission is to promote medical science and its translation into benefits for society. The Academy’s elected Fellows are the United Kingdom’s leading medical scientists from hospitals, academia, industry and the public service. We work with them to promote excellence, influence policy to improve health and wealth, nurture the next generation of medical researchers, link academia, industry and the NHS, seize international opportunities and encourage dialogue about the medical sciences. The Academy of Medical Sciences’ FORUM The Academy’s FORUM was established in 2003 to recognise the role of industry in medical research, and to catalyse connections across industry and academia. Since then, a range of FORUM activities and events have brought together researchers, research funders and research users from across academia, industry, government, and the charity, healthcare and regulatory sectors. The FORUM is a major component of the Academy's work to deliver the strategic objective of 'linking academia, industry and the NHS' and its success relies on supporter organisations who make an annual donation. We are grateful for the support provided by the members and are keen to encourage more organisations to take part. If you would like information on becoming a member please contact [email protected]. The Wellcome Trust The Wellcome Trust is a global charitable foundation dedicated to improving health.
    [Show full text]
  • Health Innovation: Breathing Life Into the Northern Powerhouse ABOUT the AUTHOR Luke Raikes Is a Research Fellow at IPPR
    REPORT HEALTH INNOVATION BREATHING LIFE INTO THE NORTHERN POWERHOUSE Luke Raikes November 2016 © IPPR North 2016 Institute for Public Policy Research ABOUT IPPR NORTH SUPPORTED BY IPPR North is IPPR’s dedicated thinktank for the North of England. With its head office in Manchester and representatives in Newcastle, IPPR North’s research, together with our stimulating and varied events programme, seeks to produce innovative policy ideas for fair, democratic and sustainable communities across the North of England. IPPR’s purpose is to conduct and promote research into, and the education of the public in, the economic, social and political sciences, science and technology, the voluntary sector and social enterprise, Established in 2011, NHSA Ltd represents the eight public services, and industry and commerce. research-intensive universities (also known as the N8), eight research-intensive NHS teaching trusts and four IPPR North academic health science networks (AHSNs), and works 13th Floor, City Tower to promote and partner the North with international Piccadilly Plaza, Manchester M1 4BT clinical research in the public and private sector. T: +44 (0)161 694 9680 E: [email protected] www.ippr.org/north Registered charity no: 800065 (England and Wales), SC046557 (Scotland). This paper was first published in November 2016. © 2016 The contents and opinions expressed in this paper are those of the author only. IDEAS to CHANGE LIVES CONTENTS Summary ................................................................................................ 3 1. Introduction and context .................................................................... 6 1.1 The strengths of the northern health science sector ...................... 6 1.2 The Northern Independent Economic Review ................................ 7 1.3 The northern powerhouse and place-based industrial strategy .....
    [Show full text]
  • Relational Regions 'In the Making': Institutionalising
    RELATIONAL REGIONS ‘IN THE MAKING’: INSTITUTIONALISING NEW REGIONAL GEOGRAPHIES OF HIGHER EDUCATION John Harrison* / Darren P Smith / Chloe Kinton Department of Geography School of Social, Political and Geographical Sciences Loughborough University Loughborough United Kingdom LE11 3TU +44(0)1509 228198 [email protected] / [email protected] / [email protected] *Author for correspondence Final author version – February 2017 Accepted for publication in Regional Studies. Page | 1 Abstract This paper advances current debates on relational regions and higher education through a unique focus on the rise of transregional university alliances. We examine the formation of university research and training consortia to make a series of wider arguments about the new spatialities of higher education praxis, the construction of new regional identities, and processes of institutionalising relational regions. Our research shows new partnership working between universities to be conducive to the weakening of fixed regional territories. It then illustrates how and why some relational imaginaries are beginning to crystallise into harder institutional forms, before revealing significant political- economic and societal implications arising from new institutional geographies of higher education. Furthermore, our research reveals the concerted theoretical and empirical attention required to develop vocabulary and frameworks better able to comprehend emergent regional worlds. For our part, we distinguish between territorial, archipelagic, de facto
    [Show full text]